Showing results (301-310 of 676) with videos related to
Sort By:
Pageof 68
Clinical Advances in Hematology & Oncology : H&O|October 6, 2025
Cancer and cardiovascular health: a multidisciplinary approachSusan DentClinical Advances in Hematology & Oncology : H&O|January 31, 2024
Risk factors for disease progression and treatment goals in polycythemia veraJulian A Waksal, Nicole E Wagner, John O MascarenhasClinical Advances in Hematology & Oncology : H&O|January 31, 2024
Evolving applications of liquid biopsies in gastrointestinal cancersPeter Li, Christian Agbisit, Marcus Noel, et al.Clinical Advances in Hematology & Oncology : H&O|August 2, 2023
New drug approvals in prostate cancer and their effect on the treatment landscapeChinmay Jani, Nour Abdallah, Pavlina Chrysafi, et al.Clinical Advances in Hematology & Oncology : H&O|May 13, 2024
Immune checkpoint inhibitor therapy in locally advanced MSI GI malignanciesEmily C Harrold, Fergus Keane, Andrea CercekClinical Advances in Hematology & Oncology : H&O|August 30, 2023
Predicting outcomes and monitoring disease in patients with multiple myelomaSusanna Kim, James R BerensonClinical Advances in Hematology & Oncology : H&O|September 16, 2026
Neoadjuvant therapies in high-risk localized prostate cancer: past, present, and futureSonam Saxena, Jake O'Hara, Qilin Cao, et al.Clinical Advances in Hematology & Oncology : H&O|April 7, 2022
Prostate-specific membrane antigen-targeted theranostics: past, present, and future approachesNathan M Hawkey, Alton O Sartor, Michael J Morris, et al.Clinical Advances in Hematology & Oncology : H&O|April 7, 2022
Immunotherapy for ovarian cancerRebecca Porter, Ursula A MatulonisClinical Advances in Hematology & Oncology : H&O|August 18, 2010
Clinical Roundtable Monograph: current treatment options for NHL patients refractory to standard therapy: recent data in single-agent and combination therapyBrad S Kahl, Bruce D Cheson, Jonathan W FriedbergPageof 68